A detailed history of Bullseye Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bullseye Investment Management, LLC holds 249 shares of LLY stock, worth $198,121. This represents 0.32% of its overall portfolio holdings.

Number of Shares
249
Previous 301 17.28%
Holding current value
$198,121
Previous $272,000 19.12%
% of portfolio
0.32%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $40,151 - $49,921
-52 Reduced 17.28%
249 $220,000
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $10,148 - $12,726
14 Added 4.88%
301 $272,000
Q1 2024

May 20, 2024

BUY
$592.2 - $792.28 $169,961 - $227,384
287 New
287 $223,000
Q4 2022

Jan 24, 2023

BUY
$321.55 - $374.67 $1.66 Million - $1.94 Million
5,177 New
5,177 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bullseye Investment Management, LLC Portfolio

Follow Bullseye Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Investment Management, LLC with notifications on news.